Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 12, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2019. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 4.6B USD
- Positions
- 224
- Share of the ten largest
- 43.7%
The ten largest positions Q3 2019
- Tesla, Inc. 6.2%▲ +0.8%
- FMS Enterprises Migun Ltd 4.8%new
- Block, Inc. 4.6%▲ +36.6%
- Illumina, Inc. 4.6%▲ +29.4%
- Fattal Holdings 1998 Ltd 4.3%new
- One Software Technologies Ltd 4.1%new
- Bet Shemesh Engines Holdings 1 4.1%▼ −25.7%
- Matrix IT Ltd 3.8%new
- Stratasys Ltd 3.6%▲ +1.2%
- Partner Communications Co Ltd 3.6%new
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q3 2019
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TSLA Tesla, Inc. | 6.2% | 1,172,610 | 282.4M USD | +0.8% increased | Q4 2016 or earlier 12 quarters |
| XYZ Block, Inc. | 4.6% | 3,424,085 | 212.1M USD | +36.6% increased | Q4 2016 or earlier 12 quarters |
| ILMN Illumina, Inc. | 4.6% | 695,310 | 211.5M USD | +29.4% increased | Q4 2016 or earlier 12 quarters |
| Stratasys Ltd | 3.6% | 7,804,069 | 166.3M USD | +1.2% increased | Q4 2016 or earlier 12 quarters |
| CRISPR Therapeutics AG | 2.5% | 2,782,140 | 114.0M USD | +2.1% increased | Q2 2017 10 quarters |
| Intellia Therapeutics Inc | 2.5% | 8,470,576 | 113.1M USD | +2.8% increased | Q4 2016 or earlier 12 quarters |
| Editas Medicine Inc | 2.4% | 4,932,398 | 112.2M USD | +1.7% increased | Q1 2017 11 quarters |
| 2U Inc | 1.8% | 5,071,776 | 82.6M USD | +261.2% increased | Q4 2016 or earlier 12 quarters |
| Splunk Inc | 1.7% | 667,462 | 78.7M USD | +31.6% increased | Q4 2016 or earlier 12 quarters |
| Xilinx Inc | 1.7% | 810,328 | 77.7M USD | +72.2% increased | Q4 2016 or earlier 12 quarters |
| Proto Labs Inc | 1.5% | 680,038 | 69.4M USD | +44.4% increased | Q4 2016 or earlier 12 quarters |
| LendingTree Inc | 1.5% | 221,461 | 68.7M USD | +123.7% increased | Q4 2016 or earlier 12 quarters |
| Materialise NV | 1.1% | 2,819,385 | 52.1M USD | +1.0% increased | Q4 2016 or earlier 12 quarters |
| Cerus Corp | 1.0% | 8,683,170 | 44.8M USD | +2.2% increased | Q4 2016 or earlier 12 quarters |
| Syros Pharmaceuticals Inc | 0.9% | 3,834,728 | 39.8M USD | +1.1% increased | Q4 2016 or earlier 12 quarters |
| NFLX Netflix | 0.8% | 141,083 | 37.8M USD | +19.9% increased | Q4 2016 or earlier 12 quarters |
| Compugen Ltd | 0.8% | 8,691,317 | 36.8M USD | +2.3% increased | Q4 2016 or earlier 12 quarters |
| APTV Aptiv | 0.8% | 395,575 | 34.6M USD | +422.3% increased | Q4 2017 8 quarters |
| ADSK Autodesk | 0.6% | 201,258 | 29.7M USD | +512.7% increased | Q4 2016 or earlier 12 quarters |
| Roku Inc | 0.6% | 289,270 | 29.4M USD | +273.6% increased | Q2 2019 2 quarters |
| Eventbrite Inc | 0.6% | 1,660,664 | 29.4M USD | +0.8% increased | Q4 2018 4 quarters |
| Seres Therapeutics Inc | 0.6% | 7,074,965 | 28.4M USD | +0.5% increased | Q4 2016 or earlier 12 quarters |
| MELI MercadoLibre | 0.5% | 37,911 | 20.9M USD | +158.5% increased | Q4 2016 or earlier 12 quarters |
| IOVA Iovance Biotherapeutics | 0.3% | 814,796 | 14.8M USD | +0.9% increased | Q1 2018 7 quarters |
| Arcturus Therapeutics Holdings | 0.3% | 1,274,413 | 13.1M USD | +26.9% increased | Q2 2019 2 quarters |
| Cellectis SA | 0.3% | 1,239,863 | 12.9M USD | +12.4% increased | Q1 2017 11 quarters |
| Ionis Pharmaceuticals Inc | 0.3% | 196,669 | 11.8M USD | +24.7% increased | Q4 2016 or earlier 12 quarters |
| REGN Regeneron Pharmaceuticals | 0.2% | 40,073 | 11.1M USD | +40.1% increased | Q4 2016 or earlier 12 quarters |
| Inovio Pharmaceuticals Inc | 0.2% | 4,222,690 | 8.7M USD | +6.8% increased | Q4 2016 or earlier 12 quarters |
| Codexis Inc | 0.2% | 630,461 | 8.6M USD | +86.9% increased | Q4 2018 4 quarters |
| TWLO Twilio | 0.2% | 66,094 | 7.3M USD | +11.3% increased | Q4 2018 4 quarters |
| CareDx Inc | 0.2% | 317,300 | 7.2M USD | +148.7% increased | Q2 2019 2 quarters |
| Twist Bioscience Corp | 0.1% | 245,627 | 5.9M USD | +14.9% increased | Q2 2019 2 quarters |
| Rubius Therapeutics Inc | 0.1% | 730,890 | 5.7M USD | +4.7% increased | Q3 2018 5 quarters |
| Fate Therapeutics Inc | 0.1% | 339,039 | 5.3M USD | +52.7% increased | Q2 2019 2 quarters |
| Cellular Biomedicine Group Inc | 0.1% | 349,625 | 5.2M USD | +11.2% increased | Q1 2019 3 quarters |
| Guardant Health Inc | 0.1% | 74,203 | 4.7M USD | +0.2% increased | Q2 2019 2 quarters |
| Personalis Inc | < 0.1% | 299,464 | 4.4M USD | +51.5% increased | Q2 2019 2 quarters |
| JD JD.com (ADR) | < 0.1% | 150,755 | 4.3M USD | +2.3% increased | Q3 2017 9 quarters |
| WDAY Workday, Inc. | < 0.1% | 15,131 | 2.6M USD | +16,346.7% increased | Q4 2017 8 quarters |
| Guidewire Software Inc | < 0.1% | 21,911 | 2.3M USD | +22.3% increased | Q4 2017 8 quarters |
| Rakuten Inc | < 0.1% | 233,205 | 2.3M USD | +5.6% increased | Q4 2017 8 quarters |
| INTU Intuit | < 0.1% | 8,549 | 2.3M USD | +2.9% increased | Q2 2017 10 quarters |
| LINE Corp | < 0.1% | 80,154 | 2.3M USD | +6.4% increased | Q1 2019 3 quarters |
| 3D Systems Corp | < 0.1% | 246,937 | 2.0M USD | +9.2% increased | Q4 2016 or earlier 12 quarters |
| ICE Intercontinental Exchange | < 0.1% | 21,364 | 2.0M USD | +37.7% increased | Q1 2018 7 quarters |
| SBI Holdings Inc/Japan | < 0.1% | 89,800 | 1.9M USD | +5.2% increased | Q4 2017 8 quarters |
| HDFC Bank Ltd | < 0.1% | 27,516 | 1.6M USD | +252.5% increased | Q4 2017 8 quarters |
| IBKR Interactive Brokers | < 0.1% | 28,010 | 1.5M USD | +4.1% increased | Q4 2017 8 quarters |
| Adyen NV | < 0.1% | 2,212 | 1.4M USD | +29.2% increased | Q1 2019 3 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 83 positions.
Breakdown by sector
- Consumer Discretionary 7.3%
- Technology 6.4%
- Health Care 5.8%
- Financials 4.9%
- Communication Services 1.0%
- Industrials < 0.1%
- not in our coverage 74.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors